Transforming molecular information
Go to content
Contact
IntegraGen on Twitter
IntegraGen on LinkedIn
IntegraGen - RSS feed
About Us
Company Overview
Management Team
Board of Directors
ISO 13485:2016 Certification
IntegraGen Genomics
miRpredX 31-3p
miRpredX 31-3p kit
Kit Contents
Testing Basics
Ordering Information
Documentation and Downloads
miR‐31‐3p and colorectal cancer
miR-31-3p Clinical data
miR-31-3p presentations and publications
Scientific Advisors
Oncology
miRpredX 31-3p
MERCURY
Lung Cancer
Oncology News
News and Events
Press releases
Latest News
Upcoming Events
Investors
Corporate Presentations
Share Information
Number of shares and voting rights
Press releases
Calendar for Publications
Financial Documents
Financial Reports
Liquidity Contract
Shareholder Meetings
Investor Contacts
Join our mailing list
Contact Us
Office locations
Need Directions?
Contact form
Join our mailing list
Careers
Experts in genomic analysis and bioinformatics
Learn more »
Molecular tumor profiling for transitional & clinical research
Learn more »
Changing the way you analyze your exome data
Learn more »
Learn more »
IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
"Helping you to find"
Learn more
miRpredX 31-3p
The first positive theranostic test for patients with metastatic colorectal cancer
Learn more
Investors
Learn more about IntegraGen
Learn more
Latest news
// Archive
Press releases
IntegraGen Reports 2018 Annual Results
Events
IntegraGen to present at 6th annual Portzamparc MidCap Conference – April 10, 2019
Press releases
IntegraGen and Advanced Biological Laboratories sign global licensing agreement for the commercialization of miRpredX test
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
